Participants
MDD, Schizophrenia, Affective Disorders
Eligible participants will be 13–18-year-old adolescents with a current diagnosis of MDD, assessed via the Kiddie-Schedule for Affective Disorders and Schizophrenia (K-SADS) [Participants will be recruited from Columbia University (CU) and Northeastern University (NEU) with a goal to enroll 110 participants equally divided by sex assigned at birth, with 90 fully completing the study (45 per site). Study advertisements will be placed in various locations in the greater New York/New Jersey and Boston areas, including Columbia University Irving Medical Center (CUIMC), New York State Psychiatric Institute (NYSPI), and NEU. Advertisements also will be posted online on social media (e.g., Facebook, Instagram). Individuals also will be recruited through clinician referrals.